Unternehmen
MU JHU CARE LIMITED
MU JHU CARE LIMITED – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
Sustainable Management in Inpatient Long Term Care in Germany Through Competence Based Staffing
Despite care being an economic sector, there is still only limited scientific knowledge about the deployment of competence-based… Beitrag ansehen →
Projekt
→
Künstliche Intelligenz in Anästhesiologie und Intensivmedizin : AI × AI
Introduction: Artificial intelligence (AI) has the potential to improve decision-making in anesthesiology and intensive care, yet… Beitrag ansehen →
Projekt
→
Enhancing emergency department safety, efficacy and cost-effectiveness by artificial intelligence
* Background: Emergency care costs are increasing in developed societies, both in rates of emergency department (ED) visits per p… Beitrag ansehen →
Projekt
→
Medical Image Analysis with Normative Machine Learning
As one of the most important aspects of diagnosis, treatment planning, treatment delivery, and follow-up, medical imaging provide… Beitrag ansehen →
Projekt
→
DVD-readable opto-electrochemical Lab-on-a-Disc as small-factor wearable wireless medical device for obesity management
Obesity is one of the most common and costly chronic disorder worldwide, and is a causal or a strong risk factor for several como… Beitrag ansehen →
Projekt
→
Limited discriminatory value of C-reactive protein for viral coinfection and respiratory severity in children evaluated in the emergency department for acute respiratory tract illness
Background C-reactive protein is often measured in children who present to an acute care facility with acute respiratory tract il… Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- Severe neonatal infection adaptive platform trials in Africa SNIP-AFRICA aims to establish a clinical research network and architecture to implement adaptive platform tri… →
- PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT) Two vaccines designed for pregnant women, to protect their unborn infant, are entering late phase development… →